MAPK8 and metabolic dysfunction-associated steatotic liver disease: This inhibition was achieved by reducing the JNK/c-Jun/inflammatory axis and JNK/CHOP/apoptotic signaling, which may contribute to resistance against the transformation of NAFLD into NASH [43].